Evidence map›Paper›PMID 35872704›Full record

ArticleInternational journal of public health2022

The Power of Advocacy: Advancing Vision for Everyone to Meet the Sustainable Development Goals.

Eva Lazuka-Nicoulaud, Kovin Naidoo, Kristan Gross, Judith Marcano Williams, Andrea Kirsten-Coleman

Abstract read
In one paragraph

Article in International journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The importance of advocacy in advancing stroke care: The global stroke action coalition.International journal of stroke : official journal of the International Stroke Society · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eva Lazuka-NicoulaudVision Impact Institute, Paris, France.
Kovin NaidooOneSight EssilorLuxottica Foundation, Durban, South Africa.
Kristan GrossVision Impact Institute, Dallas, TX, United States.
Judith Marcano WilliamsVision Impact Institute, Dallas, TX, United States.
Andrea Kirsten-ColemanVision Impact Institute, Dallas, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advocacy is instrumental to achieving significant policy change for vision. Global advocacy efforts over the past decades enabled recognition of vision as a major public health, human rights, and development issue. The United Nations General Assembly adopted its first-ever Resolution on vision: "Vision for Everyone-Accelerating Action to Achieve the Sustainable Development Goals (SDGs)" on 23 July 2021. The Resolution sets the target and commits the international community to improve vision for the 1.1 billion people living with preventable vision impairment by 2030. To fulfill their commitments, governments and international institutions must act now. Advocacy remains instrumental to mobilize funding and empower governments and stakeholders to include eye health in their implementation agenda. In this paper, we discuss the pivotal role advocacy plays in advancing vision for everyone now and in the post-COVID-19 era. We explore the link between improved eye health and the advancement of SDGs and define the framework and key pillars of advocacy to scaling-up success by 2030.

Indexed as

COVID-19Sustainable DevelopmentGlobal HealthHuman RightsHumansPublic HealthUnited Nationsadvocacyeye healthpublic healthSDGsSustainable Development Goalsuncorrected refractive errorUREvision care

Identifiers

PMID35872704
PMCPMC9296777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.